Long-distance retrograde effects of botulinum neurotoxin A

Journal of Neuroscience

Volumn 28, Issue 14, 2008, Pages 3689-3696

  Antonucci, Flavia ^a   Rossi, Chiara ^a   Gianfranceschi, Laura ^b   Rossetto, Ornella ^c   Caleo, Matteo ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Hippocampus; Retrograde axonal transport; SNAP 25; Synaptic transmission; Transcytosis; Visual system

Indexed keywords

BETA TUBULIN; BOTULINUM TOXIN A; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; NERVE PROTEIN; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FACIAL NERVE NUCLEUS; HEMISPHERE; HIPPOCAMPUS; MOTONEURON; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; OPTIC TECTUM; PRIORITY JOURNAL; RAT; RETINA; SYNAPSE; TRANSCYTOSIS; VIBRISSA; ACTION POTENTIAL; ANIMAL; C57BL MOUSE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; HEMISPHERIC DOMINANCE; INNERVATION; LIMBIC SYSTEM; METABOLISM; NERVE CELL; NERVE TRACT; PHYSIOLOGY; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT; TIME; VISUAL SYSTEM;

ACTION POTENTIALS; ANIMALS; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNCTIONAL LATERALITY; LIMBIC SYSTEM; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONS; NEUROTOXINS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TIME FACTORS; VIBRISSAE; VISUAL PATHWAYS;

EID: 43649099645     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0375-08.2008     Document Type: Article

References (44)

1. Abbruzzese G, Berardelli A (2006) Neurophysiological effects of botulinum toxin type A. Neurotox Res 9:109-114.
2. Antonucci F, Di Garbo A, Novelli E, Manno I, Sartucci F, Bozzi Y, Caleo M (2007) Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy. Exp Neurol, in press.
3. Caleo M, Lodovichi C, Maffei L (1999) Effects of nerve growth factor on visual cortical plasticity require afferent electrical activity. Eur J Neurosci 11:2979-2984.
4. Caleo M, Restani L, Gianfranceschi L, Costantin L, Rossi C, Rossetto O, Montecucco C, Maffei L (2007) Transient synaptic silencing of developing striate cortex has persistent effects on visual function and plasticity. J Neurosci 27:4530-4540.
5. Costantin L, Bozzi Y, Richichi C, Viegi A, Antonucci F, Funicello M, Gobbi M, Mennini T, Rossetto O, Montecucco C, Maffei L, Vezzani A, Caleo M (2005) Antiepileptic effects of botulinum neurotoxin E. J Neurosci 25:1943-1951.
6. Davletov B, Bajohrs M, Binz T (2005) Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins. Trends Neurosci 28:446-452.
7. Deinhardt K, Schiavo G (2005) Endocytosis and retrograde axonal traffic in motor neurons. Biochem Soc Symp 139-150.
8. Deinhardt K, Berninghausen O, Willison HJ, Hopkins CR, Schiavo G (2006) Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol 174:459-471.
9. Dolly JO, Aoki KR (2006) The structure and mode of action of different botulinum toxins. Eur J Neurol 13 [Suppl 4]:1-9.
10. Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312:592-596.
11. Eleopra R, Tugnoli V, Quatrale R, Rossetto O, Montecucco C (2004) Different types of botulinum toxin in humans. Mov Disord 19 [Suppl 8]:S53-S59.
12. Foster KA, Bigalke H, Aoki KR (2006) Botulinum neurotoxin: from laboratory to bedside. Neurotox Res 9:133-140.
13. Franchi G (2002) Time course of motor cortex reorganization following botulinum toxin injection into the vibrissal pad of the adult rat. Eur J Neurosci 16:1333-1348.
14. Franchi G, Veronesi C (2004) Time course for the reappearance of vibrissal motor representation following botulinum toxin injection into the vibrissal pad of the adult rat. Eur J Neurosci 20:1873-1884.
15. Garner CG, Straube A, Witt TN, Gasser T, Oertel WH (1993) Time course of distant effects of local injections of botulinum toxin. Mov Disord 8:33-37.
16. Giladi N (1997) The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 152:132-135.
17. Gilio F, Curra A, Lorenzano C, Modugno N, Manfredi M, Berardelli A (2000) Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol 48:20-26.
18. Habermann E (1974) 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedebergs Arch Pharmacol 281:47-56.
19. Johnson EA (1999) Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu Rev Microbiol 53:551-575.
20. Kanovsky P, Streitova H, Dufek J, Znojil V, Daniel P, Rektor I (1998) Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A. Mov Disord 13:108-117.
21. Keller JE, Neale EA, Oyler G, Adler M (1999) Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett 456:137-142.
22. Kim DY, Oh BM, Paik NJ (2006) Central effect of botulinum toxin type A in humans. Int J Neurosci 116:667-680.
23. Lalli G, Bohnert S, Deinhardt K, Verastegui C, Schiavo G (2003) The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol 11:431-437.
24. Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580:2011-2014.
25. Montecucco C, Molgo J (2005) Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol 5:274-279.
26. Montecucco C, Schiavo G, Pantano S (2005) SNARE complexes and neuroexocytosis: how many, how close? Trends Biochem Sci 30:367-372.
27. Moreno-Lopez B, de la Cruz RR, Pastor AM, Delgado-Garcia JM (1997a) Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: alterations of the discharge pattern. Neuroscience 81:437-455.
28. Moreno-Lopez B, Pastor AM, de la Cruz RR, Delgado-Garcia JM (1997b) Dose-dependent, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat. Neurology 48:456-464.
29. Pastor AM, Moreno-Lopez B, De La Cruz RR, Delgado-Garcia JM (1997) Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and synaptic alterations. Neuroscience 81:457-478.
30. Paxinos G (2004) The rat nervous system. Oxford: Elsevier.
31. Priori A, Berardelli A, Mercuri B, Manfredi M (1995) Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 118:801-807.
32. Rind HB, Butowt R, von Bartheld CS (2005) Synaptic targeting of retrogradely transported trophic factors in motoneurons: comparison of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, and cardiotrophin-1 with tetanus toxin. J Neurosci 25:539-549.
33. Rossetto O, Morbiato L, Caccin P, Rigoni M, Montecucco C (2006) Presynaptic enzymatic neurotoxins. J Neurochem 97:1534-1545.
34. Schiavo G, Montecucco C (1995) Tetanus and botulism neurotoxins: isolation and assay. Methods Enzymol 248:643-652.
35. Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717-766.
36. Schwab ME, Suda K, Thoenen H (1979) Selective retrograde transsynaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport. J Cell Biol 82:798-810.
37. Sudhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27:509-547.
38. Tropea D, Caleo M, Maffei L (2003) Synergistic effects of brain-derived neurotrophic factor and chondroitinase ABC on retinal fiber sprouting after denervation of the superior colliculus in adult rats. J Neurosci 23:7034-7044.
39. Turton K, Chaddock JA, Acharya KR (2002) Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 27:552-558.
40. Verderio C, Rossetto O, Grumelli C, Frassoni C, Montecucco C, Matteoli M (2006) Entering neurons: botulinum toxins and synaptic vesicle recycling. EMBO Rep 7:995-999.
41. von Bartheld CS (2004) Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens. J Neurobiol 58:295-314.
42. Wang MM, Janz R, Belizaire R, Frishman LJ, Sherry DM (2003) Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina. J Comp Neurol 460:106-122.
43. Wiegand H, Erdmann G, Wellhoner HH (1976) 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 292:161-165.
44. Wohlfarth K, Schubert M, Rothe B, Elek J, Dengler R (2001) Remote F-wave changes after local botulinum toxin application. Clin Neurophysiol 112: 636-640.